From: Aptamer-based CRISPR-Cas powered diagnostics of diverse biomarkers and small molecule targets
Target | Signal | CRISPR-Cas Effector | LOD | Refs. |
---|---|---|---|---|
DNA methylation | Fluorescence | Cas12b | 10–8 nM | [6] |
Extracellular vesicle | Fluorescence | Cas12a | 100 particles/mL | [88] |
Extracellular vesicles | Fluorescence | Cas12a | 100 particles/µL | [89] |
ATP | Fluorescence | Cas12a | 0.39 μM | [67] |
Na+ | Fluorescence | Cas12a | 0.21 μM | [67] |
Aflatoxin B1 (AFB1) | Biolayer interferometry (BLI) | Cas12a | 0.8 ng mL − 1 | [90] |
Salmonella typhimurium | Electrochemical | Cas12a | 20Â CFU/mL | [38] |
Bacillus cereus | Fluorescence/RNA Light-Up | Cas13a | 10Â CFU | [91] |
PDGF-BB | Fluorescence | Cas12a | 0.75Â pM | [29] |
Telomere | Fluorescence | Cas9 | – | [92] |
17β-estradiol | Raman sensing/LFA | Cas12a | 10 pM | [93] |
Thrombin | Electrochemical | Cas12a | 1.26 fM | [40] |
ATP and Na+ | LRET | Cas12a |  ~ 18 nM and ~ 0.37 μM | [68] |
Prostate-specific antigen (PSA) | Colorimetric/AuNPs | Cas12a | 0.030Â ng/ mL | [69] |
Cardiac troponin I (cTnI) | Fluorescence | Cas13d | 12.6Â pM | [87] |